Home2024April (Page 14)

ProteoGenix and Cizzle Biotechnology Announce Successful Development of New Antibodies for Early Lung Cancer DetectionSchiltigheim, France – In a groundbreaking collaboration, ProteoGenix, a leading antibody development contract research organization (CRO), has partnered with Cizzle Biotechnology Holdings PLC, an innovative UK-based diagnostics developer, to develop new

<?xml encoding="utf-8" ?????????>Potholes plaguing British roads exact a heavy toll on the economy, with the total cost surpassing £14 billion annually, according to recent findings.The Centre for Economics and Business Research (CEBR) sheds light on the multifaceted impact of road damage, encompassing repair expenses, traffic